United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $776,550,129.77
- Nov. 21, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 13, 2014 | CEO | 2,592 | $124.31 | Sell | $322,211.52 | |
Oct. 9, 2014 | CEO | 9,662 | $129.97 | Sell | $1,255,770.14 | |
Oct. 9, 2014 | EVP | 5,000 | $130.59 | Sell | $652,950.00 | |
Oct. 8, 2014 | CEO | 2,211 | $131.50 | Sell | $290,746.50 | |
Oct. 7, 2014 | COO | 35,000 | $130.14 | Sell | $4,554,900.00 | |
Oct. 6, 2014 | CEO | 2,592 | $129.32 | Sell | $335,197.44 | |
Oct. 3, 2014 | COO | 10,000 | $129.79 | Sell | $1,297,900.00 | |
Oct. 2, 2014 | EVP | 6,000 | $129.46 | Sell | $776,760.00 | |
Oct. 2, 2014 | CFO | 10,000 | $129.46 | Sell | $1,294,600.00 | |
Oct. 2, 2014 | CEO | 9,662 | $127.72 | Sell | $1,234,030.64 | |
Oct. 2, 2014 | Director | 1,500 | $130.65 | Sell | $195,975.00 | |
Oct. 1, 2014 | CEO | 2,211 | $127.40 | Sell | $281,681.40 | |
Sept. 30, 2014 | COO | 20,000 | $128.65 | Sell | $2,573,000.00 | |
Sept. 25, 2014 | CEO | 5,547 | $134.26 | Sell | $744,740.22 | |
Sept. 25, 2014 | Director | 20,000 | $134.94 | Sell | $2,698,800.00 | |
Sept. 25, 2014 | EVP | 5,000 | $133.77 | Sell | $668,850.00 | |
Sept. 23, 2014 | COO | 50,000 | $131.02 | Sell | $6,551,000.00 | |
Sept. 19, 2014 | COO | 10,000 | $129.60 | Sell | $1,296,000.00 | |
Sept. 18, 2014 | CFO | 10,000 | $130.93 | Sell | $1,309,300.00 | |
Sept. 18, 2014 | EVP | 6,000 | $130.93 | Sell | $785,580.00 | |
Sept. 18, 2014 | CEO | 9,662 | $127.35 | Sell | $1,230,455.70 | |
Sept. 17, 2014 | COO | 20,000 | $127.01 | Sell | $2,540,200.00 | |
Sept. 15, 2014 | CEO | 50,000 | $124.52 | Sell | $6,226,000.00 | |
Sept. 11, 2014 | EVP | 5,000 | $120.70 | Sell | $603,500.00 | |
Sept. 11, 2014 | CEO | 9,662 | $120.79 | Sell | $1,167,072.98 | |
Sept. 10, 2014 | CEO | 50,000 | $120.01 | Sell | $6,000,500.00 | |
Sept. 10, 2014 | Director | 20,000 | $119.95 | Sell | $2,399,000.00 | |
Sept. 5, 2014 | COO | 10,000 | $111.29 | Sell | $1,112,900.00 | |
Sept. 4, 2014 | Director | 3,000 | $113.40 | Sell | $340,200.00 | |
Sept. 4, 2014 | CFO | 10,000 | $112.38 | Sell | $1,123,800.00 | |
Sept. 4, 2014 | CEO | 9,662 | $112.87 | Sell | $1,090,549.94 | |
Sept. 4, 2014 | EVP | 6,000 | $112.38 | Sell | $674,280.00 | |
Aug. 28, 2014 | EVP | 5,000 | $92.07 | Sell | $460,350.00 | |
Aug. 28, 2014 | CEO | 7,014 | $92.46 | Sell | $648,514.44 | |
Aug. 21, 2014 | CEO | 9,640 | $93.13 | Sell | $897,773.20 | |
Aug. 21, 2014 | CFO | 10,000 | $93.75 | Sell | $937,500.00 | |
Aug. 15, 2014 | Director | 1,500 | $91.14 | Sell | $136,710.00 | |
Aug. 14, 2014 | EVP | 10,000 | $88.41 | Sell | $884,100.00 | |
Aug. 14, 2014 | CEO | 4,115 | $88.39 | Sell | $363,724.85 | |
Aug. 7, 2014 | CEO | 4,115 | $88.40 | Sell | $363,766.00 | |
Aug. 7, 2014 | Director | 5,000 | $88.23 | Sell | $441,150.00 | |
Aug. 7, 2014 | CFO | 10,000 | $86.44 | Sell | $864,400.00 | |
Aug. 1, 2014 | Director | 3,000 | $89.52 | Sell | $268,560.00 | |
Aug. 1, 2014 | COO | 10,000 | $89.88 | Sell | $898,800.00 | |
July 31, 2014 | CEO | 3,933 | $90.95 | Sell | $357,706.35 | |
July 29, 2014 | COO | 50,000 | $96.25 | Sell | $4,812,500.00 | |
July 25, 2014 | COO | 10,000 | $91.54 | Sell | $915,400.00 | |
July 24, 2014 | CEO | 9,228 | $93.15 | Sell | $859,588.20 | |
July 17, 2014 | CFO | 10,000 | $89.74 | Sell | $897,400.00 | |
July 17, 2014 | CEO | 3,833 | $90.87 | Sell | $348,304.71 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 21, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.